Key Issues in Pharmaceuticals Law
The focus of Key Issues in Pharmaceuticals Law is on the ongoing achievement of an authentic world code for medicinal products a so-called Pharmacopoeia through scientific technical harmonization. The legal dimension of medicinal products conditions More...
This item will ship on
Wednesday, August 5.
day, 100% Satisfaction Guarantee
Publisher: IOS Press, Incorporated
Size: 6.50" wide x 9.50" long x 0.50" tall
The focus of Key Issues in Pharmaceuticals Law is on the ongoing achievement of an authentic world code for medicinal products a so-called Pharmacopoeia through scientific technical harmonization. The legal dimension of medicinal products conditions the whole sector and it acquires a global dimension through the demand to protect people's health. Hence it is necessary to go forward to total harmonization of all its aspects. A global legal statute for medicinal products is justified by the very nature of the product, by its social control and the need for it to circulate freely, although limitations can be accepted, for reasons of solidarity with less favored populations. Awareness must arise that the challenge for healthcare is not going to find an adequate answer at the world level without a qualitative change in the world organization of the UN. The globalized world we live in demands reinforced continental solidarity, if we are to confront the common problems and bring about international order. A scientific technical code on the quality of medicinal products is essential for a statute on medicines. That code is the Pharmacopoeia.
|Toward a global legal statute for medicinal products|
|The European Union's advanced therapies proposal: The rapporteur's perspective|
|The Regulation of Orphan Medicines in the EU; Objectives reached and main challenges when facing the future|
|New challenges for the Coordination Group for Mutual recognition and Decentralised procedures|
|The International Pharmacopoeia in the changing environment|
|Internationalisation of regulatory requirements|
|The Australian government's review of the plasma fractionation arrangements in Australia|
|Recent changes to the Czech legal framework of setting the prices of pharmaceuticals paid for by the system of public health insurance|
|The impact of the new deontological code upon the pharmacist's activities in Romania|
|ISBT 128: An internationally standardized means to label cellular therapy products|
|Author Index Volume 9 (2007)|
|Table of Contents provided by Blackwell. All Rights Reserved.|